Career Enhancement Program

项目总结/摘要- CEP MSK胰腺孢子的职业提升计划（CEP）的目标是支持和指导 最有前途和积极性的早期职业调查员，为他们的独立职业做好准备， 转化研究集中在胰腺中产生的恶性肿瘤。CEP领导团队拥有强大的 出版记录，成功的指导历史，以及对教育/培训的持续承诺。的 CEP将：1）招募早期职业研究人员到胰腺癌转化研究领域， SPORE的整体翻译研究能力，并为我们的计划带来新的想法和新的人才， 2）为这些人提供有效的翻译研究所需的学术基础和指导 在胰腺癌中。CEP基金，加上机构基金，将使我们能够支持多达两个 每年都有优秀的候选人。早期职业研究人员（应用和基础科学家，临床医生， 在他们的教师任命的2年内的医生科学家）与胰腺癌的表现出兴趣 来自MSK的研究，来自三机构计划内的机构（威尔康奈尔医学院或 洛克菲勒大学），或纽约市内外的机构将有资格申请。 申请将由CEP/DRP遴选委员会进行同行评审，该委员会由SPORE PI，DRP和CEP领导人，选择MSK部门和部门主席，以及来自 MSK平等、多样性和包容理事会。最有前途的候选人，最有功勋的 根据既定的审查标准，将选择指导研究项目。将特别强调 征聘合格的妇女和任职人数不足的人口，并实施侧重于 关于胰腺癌的卫生保健差异的问题。CEP获奖者将准备一份个性化的 与他们的临床和/或实验室导师制定发展计划，并参加各种教育 课程，会议和课程，支持他们的职业发展。CEP获奖者将拥有 完全使用所有SPORE核心设施和专业知识，并将成为每月SPORE的组成部分 会议，在那里他们将展示他们的研究。CEP接受者将每年接受正式评估， 培训将在适当的时候进行修改。CEP获奖者的成功案例包括演讲/ 发表原创研究，成功竞争独立研究支持，建立 新的合作，并通过学术推广机构的认可。

PROJECT SUMMARY/ABSTRACT – CEP The goal of the Career Enhancement Program (CEP) of the MSK Pancreas SPORE is to support and mentor the most promising and motivated early-career investigators to prepare them for independent careers in translational research focused on malignancies arising in the pancreas. The CEP leadership team has a strong publication record, a history of successful mentorship, and a sustained commitment to education/training. The CEP will: 1) recruit early-career investigators to the field of translational research in pancreatic cancer to enhance the overall translational research capability of the SPORE and bring fresh ideas and new talent to our program, and 2) provide these individuals the scholarly basis and mentorship needed for effective translational research in pancreatic cancer. CEP funds, supplemented by institutional funds, will allow us to support up to two exceptional candidates each year. Early-career investigators (applied and basic scientists, clinicians, and physician-scientists within 2 years of their faculty appointment) with a demonstrated interest in pancreatic cancer research from MSK, from institutions within the Tri-Institutional Program (Weill Cornell Medical College or Rockefeller University), or institutions within and outside of New York City will be eligible to apply. Applications will be peer-reviewed by the CEP/DRP Selection Committee, which is composed of the SPORE PIs, DRP and CEP Leaders, select MSK Departmental and Divisional Chairs, and representatives from the MSK Equality, Diversity & Inclusion Council. The most promising candidates, with the most meritorious mentored research projects based on defined review criteria, will be selected. Special emphasis will be placed on recruiting qualified women and members of underrepresented populations, and on projects focused on issues pertaining to health care disparities in pancreatic cancer. CEP awardees will prepare an individualized development plan with their clinical and/or laboratory mentor(s), and take part in various educational programs, conferences, and curricula at MSK that support their career development. CEP awardees will have full access to all SPORE Core facilities and expertise, and will be an integral part of monthly SPORE meetings, where they will present their research. CEP recipients will be formally evaluated annually, and training will be modified when appropriate. Metrics of success for CEP awardees include presentation/ publication of original research, successful competition for independent research support, establishment of new collaborations, and institutional recognition by academic promotion.